PepGen (PEPG) 10-Q2024 Q1 Quarterly report

Filed: 14 May 24, 4:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. junior Good

New words: affirmative, aforementioned, artwork, Ashton, ATM, belonging, biometric, BofA, Chemistry, chief, Christopher, cohort, Connecticut, Dable, display, double, Dr, fordadistrogene, furniture, givinostat, GLP, Habib, HDAC, hereinafter, ingredient, Joshua, Leerink, McArthur, Mellion, Michelle, movaparvovec, mutual, Nevada, noncompliance, organizational, OSE, phishing, Pillar, PSU, ransomware, Resnick, RSU, Science, Senior, sponsorship, Svenstrup, TM, unrestricted, variation, Vice, visual, Washington, Wedbush

Removed: actively, added, adjusted, adjustment, AG, analogue, appointed, ASC, ASU, ataluren, Bank, basic, Biden, bind, biosimilar, burdened, bypassed, calculation, Cambridge, cardiac, Carnot, Casimersen, cell, cellular, central, Chase, classification, CNS, conditional, Congressional, conjugate, conversion, convert, CTG, curve, defect, delivered, deposit, devastating, diaphragm, discount, downstream, Eli, eliminating, ending, engineered, enhance, evergreen, exempted, exemption, factor, FASB, feasibility, feet, fixed, founding, gained, gap, hand, headquartered, HHS, HSALR, Ida, impacting, incentivize, inform, IRA, JP, July, knock, landlord, leased, leasehold, liberation, Lilly, live, Locana, mdx, mice, Morgan, morpholino, Mount, mouse, mRNA, murine, myotonia, Newton, NHP, Nippon, nonbreaching, nonsense, noted, nuclear, obligation, occupancy, optimize, owing, paragraph, peer, penetrating, penetration, pharmacologically, phosphorodiamidate, primate, progressive, proportional, proposal, quantitative, receiver, reducing, released, remeasured, remeasurement, repairing, represented, Republic, repurchase, restating, restriction, retroactively, reversal, reverse, scrutiny, segment, seized, sequester, Shinyaku, short, Signature, Silicon, Silvergate, skeletal, smooth, split, square, structurally, subcontractor, Suisse, Supplemental, swept, tolerable, traded, transformative, translated, transport, trinucleotide, truncated, UBS, undisclosed, undrawn, updated, Valley, volunteer

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PEPG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of PepGen Inc. (the “Company”) for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned officer of the Company hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to his knowledge, that:

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Date: May 14, 2024	By:	/s/ Noel Donnelly
		Noel Donnelly
		Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)